Ami Fadia
Stock Analyst at Needham
(4.95)
# 140
Out of 5,078 analysts
631
Total ratings
53.6%
Success rate
29.6%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $35 | $19.73 | +77.39% | 41 | Oct 19, 2026 | |
| ALKS Alkermes | Reiterated: Buy | $62 | $43.63 | +42.10% | 20 | Oct 19, 2026 | |
| HRMY Harmony Biosciences Holdings | Reiterated: Buy | $50 | $36.13 | +38.39% | 55 | Oct 19, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $310 | $214.00 | +44.86% | 74 | Oct 16, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $204 | $142.70 | +42.96% | 45 | Oct 16, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $268 | $145.04 | +84.78% | 27 | Oct 15, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $275 | $186.99 | +47.07% | 37 | Oct 15, 2026 | |
| BIIB Biogen | Reiterated: Buy | $256 | $250.69 | +2.12% | 72 | Oct 6, 2026 | |
| LBRX LB Pharmaceuticals | Initiated Coverage: Buy | $68 | $38.73 | +75.57% | 1 | Oct 2, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $582 | $252.96 | +130.08% | 27 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 | $35.67 | +85.03% | 12 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $43 | $7.97 | +439.52% | 9 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.3794 | +1,217.87% | 21 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $31.21 | - | 28 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $39 | $18.07 | +115.83% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $18 | $3.73 | +382.57% | 32 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $14 | $3.55 | +294.37% | 44 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €108.00 | €69.25 | n/a | 8 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $9.71 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $10.20 | n/a | 2 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $15 | $3.08 | n/a | 3 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.00 | n/a | 6 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $15.96 | n/a | 10 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5.5 → $6 | $20.38 | n/a | 9 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $11.79 | n/a | 9 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 | $36.42 | n/a | 7 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0001 | n/a | 5 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $0.000001 | n/a | 3 | Dec 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $24 | $0.3028 | n/a | 9 | Dec 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $1.5 | $0.000001 | n/a | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $12.61 | n/a | 4 | Aug 14, 2020 |
Acadia Pharmaceuticals
Oct 19, 2026
Reiterated: Buy
Price Target: $35
Current: $19.73
Upside: +77.39%
Alkermes
Oct 19, 2026
Reiterated: Buy
Price Target: $62
Current: $43.63
Upside: +42.10%
Harmony Biosciences Holdings
Oct 19, 2026
Reiterated: Buy
Price Target: $50
Current: $36.13
Upside: +38.39%
Jazz Pharmaceuticals
Oct 16, 2026
Reiterated: Buy
Price Target: $310
Current: $214.00
Upside: +44.86%
Neurocrine Biosciences
Oct 16, 2026
Reiterated: Buy
Price Target: $204
Current: $142.70
Upside: +42.96%
Axsome Therapeutics
Oct 15, 2026
Reiterated: Buy
Price Target: $268
Current: $145.04
Upside: +84.78%
Revolution Medicines
Oct 15, 2026
Reiterated: Buy
Price Target: $275
Current: $186.99
Upside: +47.07%
Biogen
Oct 6, 2026
Reiterated: Buy
Price Target: $256
Current: $250.69
Upside: +2.12%
LB Pharmaceuticals
Oct 2, 2026
Initiated Coverage: Buy
Price Target: $68
Current: $38.73
Upside: +75.57%
Praxis Precision Medicines
Sep 24, 2026
Reiterated: Buy
Price Target: $582
Current: $252.96
Upside: +130.08%
Sep 14, 2026
Reiterated: Buy
Price Target: $66
Current: $35.67
Upside: +85.03%
Aug 31, 2026
Rated: Buy
Price Target: $45 → $43
Current: $7.97
Upside: +439.52%
Aug 14, 2026
Reiterated: Buy
Price Target: $5
Current: $0.3794
Upside: +1,217.87%
Aug 11, 2026
Rated: Hold
Price Target: n/a
Current: $31.21
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $32 → $39
Current: $18.07
Upside: +115.83%
Aug 5, 2026
Reiterated: Buy
Price Target: $11 → $18
Current: $3.73
Upside: +382.57%
Jul 30, 2026
Reiterated: Buy
Price Target: $15 → $14
Current: $3.55
Upside: +294.37%
Apr 25, 2025
Reiterated: Buy
Price Target: €108.00
Current: €69.25
Upside: n/a
Dec 14, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $9.71
Upside: n/a
Mar 10, 2021
Reiterated: Buy
Price Target: $10 → $7
Current: $10.20
Upside: n/a
Mar 8, 2021
Reiterated: Buy
Price Target: $10 → $15
Current: $3.08
Upside: n/a
Mar 2, 2021
Rated: Hold
Price Target: n/a
Current: $18.00
Upside: n/a
Mar 1, 2021
Rated: Buy
Price Target: $63
Current: $15.96
Upside: n/a
Feb 26, 2021
Rated: Hold
Price Target: $5.5 → $6
Current: $20.38
Upside: n/a
Feb 25, 2021
Rated: Buy
Price Target: $16
Current: $11.79
Upside: n/a
Feb 25, 2021
Rated: Hold
Price Target: $75
Current: $36.42
Upside: n/a
Jan 11, 2021
Reiterated: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Dec 30, 2020
Reiterated: Buy
Price Target: $10 → $7
Current: $0.000001
Upside: n/a
Dec 2, 2020
Reiterated: Buy
Price Target: $19 → $24
Current: $0.3028
Upside: n/a
Oct 1, 2020
Reiterated: Hold
Price Target: $1 → $1.5
Current: $0.000001
Upside: n/a
Aug 14, 2020
Reiterated: Buy
Price Target: $8 → $9
Current: $12.61
Upside: n/a